• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec24
National Medical Insurance Bureau Launches Innovative Drug Directory for Commercial Health Insurance
16:16
Dec13
Macquarie Analyst Maintains Buy Rating on BeiGene
01:12
Dec12
BeiGene Establishes A-Share Raising Fund Management System
09:38
Dec8
UOB Securities Analysts Positive on BeiGene's Revenue Growth Potential
04:37
Dec7
Two Drugs of BeiGene Entered the Commercial Insurance Innovative Drugs Directory
03:19
Dec4
Brokers Adjust Ratings and Target Prices for Multiple Stocks
01:00

Schedules & Filings

Schedules
Filings
Jan2
Ticker Change(EST)

From 01.02 changed to ONC

Nov12
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 1.048 B, Net Income -154.1 M, EPS -1.4681

Aug7
Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 929.17 M, Net Income -120.41 M, EPS -1.15

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More